xpertsystems/hccar002-sample

HCCAR002 — 合成急性心肌梗死数据集（样本预览）是一个单表急性心肌梗死（AMI）数据集，涵盖STEMI、NSTEMI和不稳定型心绞痛患者的完整住院和1年临床数据表面。包括人口统计学和临床表现（主诉、生命体征、Killip分级）、心电图（ST段抬高/压低、节律、间期、梗死区域+STEMI导联映射）、5个时间点（0h/3h/6h/12h/24h）的连续肌钙蛋白动力学（覆盖4种检测方法：TnI常规、TnT常规、hs-TnI、hs-TnT）、额外生物标志物（CK-MB、肌红蛋白、BNP/NT-proBNP、血脂、糖化血红蛋白、eGFR、电解质、全血细胞计数、INR）、干预时间（门-球时间、门-针时间、纤溶、PCI、CABG、TIMI血流前后、支架、IABP/Impella/ECMO）、药物（DAPT、抗凝剂、GP IIb/IIIa抑制剂、β受体阻滞剂、ACEi/ARB、他汀类药物强度、溶栓剂）、超声心动图（LVEF、RWMA、左室尺寸、二尖瓣反流分级、心包积液、右室功能障碍）、风险评分（TIMI STEMI、TIMI UA/NSTEMI、GRACE住院和6个月死亡率%、CRUSADE出血、DAPT）以及30天/1年结局（住院死亡率、MACE、再入院、AKI、卒中、大出血、支架血栓形成、再梗死、住院时间、出院/90天LVEF、心脏康复转诊、合并症、Charlson指数）。该数据集针对ACC/AHA STEMI指南、第4版心肌梗死通用定义（2018）、Killip-Kimball（1967）分类、NCDR ACTION + CathPCI注册、TIMI风险评分、GRACE注册、CRUSADE出血评分和DAPT评分进行了校准。这是一个样本预览，包含200名患者×144个特征（约280 KB）。完整产品覆盖10,000多名患者，包括扩展的导管室程序细节、完整药物滴定历史、长达2年的纵向随访，以及用于STEMI临床试验模拟、NSTEMI风险分层研究和心源性休克结局分析的预建队列配置。HCCAR002 — Synthetic Acute Myocardial Infarction Dataset (Sample Preview) is a single-table acute myocardial infarction (AMI) dataset spanning the complete in-hospital and 1-year clinical data surface for STEMI, NSTEMI, and Unstable Angina patients. It includes demographics and presentation (chief complaint, vitals, Killip class), ECG (ST elevation/depression, rhythm, intervals, infarct territory + STEMI lead mapping), serial troponin kinetics at 5 timepoints (0h / 3h / 6h / 12h / 24h) across 4 assays (TnI conventional, TnT conventional, hs-TnI, hs-TnT), additional biomarkers (CK-MB, myoglobin, BNP/NT-proBNP, lipids, hemoglobin A1c, eGFR, electrolytes, CBC, INR), intervention timing (door-to-balloon, door-to-needle, fibrinolysis, PCI, CABG, TIMI flow pre/post, stents, IABP/Impella/ECMO), medications (DAPT, anticoagulants, GP IIb/IIIa inhibitors, beta-blocker, ACEi/ARB, statin intensity, thrombolytic agent), echocardiography (LVEF, RWMA, LV dimensions, MR grade, pericardial effusion, RV dysfunction), risk scores (TIMI STEMI, TIMI UA/NSTEMI, GRACE in-hospital and 6-month mortality %, CRUSADE bleeding, DAPT), and 30-day / 1-year outcomes (in-hospital mortality, MACE, readmission, AKI, stroke, major bleeding, stent thrombosis, reinfarction, LOS, LVEF discharge / 90-day, cardiac rehab referral, comorbidities, Charlson index). Calibrated against ACC/AHA STEMI Guidelines, 4th Universal Definition of MI (2018), Killip-Kimball (1967) classification, NCDR ACTION + CathPCI registries, TIMI Risk Score, GRACE Registry, CRUSADE bleeding score, and DAPT Score. This is the sample preview — 200 patients × 144 features (~280 KB). The full product covers 10,000+ patients with extended cath lab procedural detail, full medication titration histories, longitudinal follow-up to 2 years, and pre-built cohort configs for STEMI clinical trial simulation, NSTEMI risk stratification studies, and cardiogenic shock outcomes analysis.